0 Reacties
0 aandelen
743 Views
0 voorbeeld
Zoeken
Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken
-
Please log in to like, share and comment!
-
Exosomes Market to Reach USD 912.33 Million by 2033, Growing at 14.7% CAGRThe global exosomes market size was valued at USD 265.51 million in 2024 and is anticipated to grow from USD 304.54 million in 2025 to reach USD 912.33 million in 2033, growing at a CAGR of 14.7% during the forecast period (2025–2033). According to Straits Research, this report provides a clear understanding of the Exosomes Market by analyzing its overall structure, key...0 Reacties 0 aandelen 2K Views 0 voorbeeld
-
Global Hemophilia Treatment Market by 2031: Growth Trends, Recent Developments, and Future OutlookThe Global Hemophilia Treatment Market is witnessing steady expansion driven by rising awareness, improved diagnostic capabilities, and continuous advancements in therapeutic options such as gene therapy and monoclonal antibodies. Hemophilia, a rare genetic bleeding disorder, requires lifelong management, which has significantly increased the demand for advanced and effective treatment...0 Reacties 0 aandelen 719 Views 0 voorbeeld
-
Rare Neurological Disease Treatment Market Competitive Landscape and Key PlayersThe global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...0 Reacties 0 aandelen 621 Views 0 voorbeeld
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Reacties 0 aandelen 62 Views 0 voorbeeld